StartUPDATES: New developments from healthcare startups
Check out news from Carrum Health, BigHat Biosciences, YourChoice Therapeutics, and more.
Check out news from Carrum Health, BigHat Biosciences, YourChoice Therapeutics, and more.
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
Memory Health CEO Edward Shehab talked about taking a preventive approach to neurodegenerative conditions.
Check out news from Equiva, Vida Health, Canaery, and DocPanel.
The rising levels of both type 1 and type 2 diabetes in American youth is quickly becoming a major public health concern. To help address this problem, Mount Sinai partnered with mPulse Mobile, a company that offers a AI-based mobile patient messaging platform. Together with a group of teenage community members, they created a text message-based youth diabetes prevention program focused on integrating healthy behaviors into teens’ lives.
Check out new developments from Equiva, SonALAsense, Sensible Care, and more.
Check out news from Opala, Equiva, Sling Therapeutics, Quil, and Third Rock Ventures.
Check out news from Equiva, PrecisionGx, Wavemaker Three-Sixty Health, Jasper Health, and Anagenex.
Check out news from Carrum Health, Equiva, SpectrumAi, Transition Bio and SamaCare.
Check out news from Memory Health, Equiva, KAID Health, Tegria, and Japa Health.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Check out new developments from Carrum Health, ThoroughCare, Inceptor Bio and Gener8or accelerator.
Read about new developments from Healthmine, Capable Health, Imagene AI, PolyCore Therapeutics, Inc and more.
Check out new developments from Healthmine, Source Health, Amino Health, Nym Health, and Waltz Health.
Founded in 2021, Gandeeva is developing precision imaging solutions with the integration of cryo-electron microscopy (cryo-EM) and artificial intelligence. Its technology can be applied to advance drug discovery and by lowering risks of late-stage clinical failures.
Check out new developments from Seven Bridges, Healthmine, Bright Health, and My One Medical Source.